Encephalopathy in scleromyxedema

Neurology

Volumn 53, Issue 5, 1999, Pages 1138-1140

  Johkura, Ken ^c   Susuki, K ^d   Hasegawa, O ^a   Kuroiwa, Y ^a   Komatsumoto, S ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b ASHIKAGA RED CROSS HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d NONE

Author keywords

CSF; Encephalopathy; Immunoglobulin G index; Scleromyxedema

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 6; PROTEIN;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL EXAMINATION; HUMAN; MALE; MUCINOSIS; MYXEDEMA; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RECURRENT DISEASE;

EID: 0033595463     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.5.1138     Document Type: Article

References (9)

1. Perry HO, Montgomery H, Stickney JM. Further observations on lichen myxedematosus. Ann Intern Med 1960;53:955-969.
2. Webster GF, Matsuoka LY, Burchmore D. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 1993;28:105-108.
3. River Y, Levy I, Gilead L, et al. Fever, convulsions and coma in scleromyxedema: a "dermato-neuro syndrome." Neurology 1996;46:1778-1779.
4. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: WB Saunders, 1992:183-252.
5. Komatsumoto S, Isozumi K, Kojima M, Suzuki K, Nara M. Role of endotherin-1 and interleukin-6 immunoreactivity in infarcted area of human stroke. Jpn J Stroke 1997;19:103-109.
6. Ochitill HN, Amberson JAY. Acute cerebral symptomatology: a rare presentation of scleromyxedema. J Clin Psychiatry 1978; 39:474-475.
7. Bauer J, Herrmann F. Interleukin-6 in clinical medicine. Ann Hematol 1991;62:203-210.
8. Duchini A. Govindarajan S, Santucci M, Zampi G, Hofman FM. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Invest Med 1996;44:474-482.
9. Brett FM, Mizisin AP, Powell HC, Campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 1995;54:766-775.